Details for New Drug Application (NDA): 065430
NDA 065430 describes CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER, which is a drug marketed by B Braun and is included in one NDA. Additional details are available on the CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER profile page.
The generic ingredient in CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER is cefotetan disodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
The generic ingredient in CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER is cefotetan disodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for 065430
| Tradename: | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER |
| Applicant: | B Braun |
| Ingredient: | cefotetan disodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065430
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Aug 9, 2007 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Aug 9, 2007 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
